Press-release for stocks publishing date 2021 - 04

Prices are updated after-hours

publishing date : 2021 - 04 - 20 source : Www.biospace.com

save search

EyeCare Partners LLC Promotes David Clark to Chief Executive Officer
Published: 2021-04-20 (Crawled : 00:00) - biospace.com/
MD | $9.24 -1.7% 0.11% 470K

Health Services

| -65.08% | O: -0.79% H: 0.84% C: 0.27%
eye

Biomea Announces Closing of Initial Public Offering
Published: 2021-04-20 (Crawled : 00:00) - biospace.com/
BMEA | $10.76 -2.0% -2.04% 850K

Professional, Scientific, and T...

| -36.65% | O: 0.0% H: 0.0% C: -1.24%
offering publication

QIAGEN Launches artus Prep as CE-Marked SARS-CoV-2 Test Offering up to Threefold Increase in Daily Lab Testing Capacity
Published: 2021-04-20 (Crawled : 23:00) - biospace.com/
QGEN | $41.52 -0.88% 0.0% 820K

Health Technology

| -20.82% | O: -0.97% H: 0.64% C: 0.6%
QGEN | $41.52 -0.88% 0.0% 820K

Health Technology

| -20.82% | O: -0.97% H: 0.64% C: 0.6%
offering test sars-cov-2

Moderna Announces New Supply Agreement with Israel for 2022
Published: 2021-04-20 (Crawled : 23:00) - biospace.com/
MRNA | News S | $108.82 0.86% 0.85% 3.4M

Health Technology

| -32.77% | O: -0.98% H: 1.5% C: -2.21%
israel

Adesis Achieves ISO 9001:2015 Certification
Published: 2021-04-20 (Crawled : 23:00) - biospace.com/
OLED | $156.485 1.68% 1.65% 190K

Electronic Technology

| -30.99% | O: -0.5% H: 0.51% C: -2.7%

Labcorp Launches COVID-19 Test Kits for Small Businesses to Support Return to Work and Life Safely
Published: 2021-04-20 (Crawled : 23:00) - biospace.com/
LH 4 | $207.94 -0.01% 0.0% 790K

Health Services

| -20.79% | O: -0.29% H: 0.5% C: 0.1%
covid test

An Update on the J&J COVID-19 Vaccine Pause: What We Know So Far
Published: 2021-04-20 (Crawled : 22:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -8.94% | O: -1.04% H: 4.22% C: 3.4%
covid vaccine covid-19

BD Announces the Voluntary Recall of Specified Lots of ChloraPrep™ Hi-Lite Orange™ 26 mL Applicator in the United States and U.S. Territories Due to Defective Applicator
Published: 2021-04-20 (Crawled : 19:00) - biospace.com/
BDX | $233.83 -0.23% 3.49% 780K

Health Technology

| -9.7% | O: -0.09% H: 0.73% C: -0.88%
application

When Will Lecanemab be Available to Alzheimer’s Patients?
Published: 2021-04-20 (Crawled : 19:00) - biospace.com/
BIIB | $201.91 4.52% 4.32% 3.3M

Health Technology

| -24.92% | O: -0.01% H: 2.16% C: 1.56%
alzheimer alzheimer’s alzheimer's lecanemab

Presidio Medical Announces New Executive Appointment
Published: 2021-04-20 (Crawled : 18:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -8.94% | O: -1.04% H: 4.22% C: 3.4%

Reify Health Powers Patient Recruitment and Enrollment Across AstraZeneca’s Extensive Breast Cancer Clinical Trial Pipeline
Published: 2021-04-20 (Crawled : 18:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 296.65% | O: 0.41% H: 1.62% C: 0.11%
AZN | News | $71.175 0.46% 0.46% 6.1M

Health Technology

| 37.9% | O: 0.89% H: 0.5% C: 0.35%
cancer breast cancer trial enroll health

Evolent Health, Inc. to Release First Quarter 2021 Operating Results and Host Conference Call on Wednesday, May 5, 2021
Published: 2021-04-20 (Crawled : 18:00) - biospace.com/
EVH | $29.26 -2.89% -2.5% 1M

Commercial Services

| 48.08% | O: -1.11% H: 1.31% C: -2.2%
results conference

Y-mAbs Provides Regulatory Update on Omburtamab
Published: 2021-04-20 (Crawled : 18:00) - biospace.com/
YMAB | $15.26 -0.52% -0.52% 160K

Health Technology

| -39.92% | O: -1.06% H: 4.37% C: 3.69%

Agilent Named One of the Best U.S. Companies for Diversity for Third Straight Year
Published: 2021-04-20 (Crawled : 17:00) - biospace.com/
A | $137.49 -1.23% -0.36% 1.6M

Health Technology

| 2.99% | O: -0.37% H: 0.41% C: -0.41%

IN.PACT™ AV Drug-Coated Balloon Is First and Only to Show Superior and Sustained Results Through Two Years Compared to PTA in Treating Arteriovenous Fistulae Lesions
Published: 2021-04-20 (Crawled : 17:00) - biospace.com/
MDT | $80.38 -1.12% 0.0% 5M

Health Technology

| -36.27% | O: -0.17% H: 1.99% C: 1.88%
results drug

Johnson & Johnson COVID-19 Vaccine Roll-out to Resume in Europe Following European Medicines Agency (EMA) Review
Published: 2021-04-20 (Crawled : 17:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -8.94% | O: -1.04% H: 4.22% C: 3.4%
covid europe vaccine ema

Element Biosciences Appoints Chief Commercial Officer, General Counsel, and VP of Operations
Published: 2021-04-20 (Crawled : 16:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -8.94% | O: -1.04% H: 4.22% C: 3.4%
commercialization bioscience

COVID-19 News: Researchers Discover a New Variant, Antiviral Shows Promise in...
Published: 2021-04-20 (Crawled : 16:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology